摘要
目的探析优泌乐25R治疗血糖控制不佳2型糖尿病的有效性和安全性。方法将该院收治的60例血糖控制不佳2型糖尿病患者随机分为研究组和对照组,给予对照组患者皮下注射门冬胰岛素30注射液治疗,给予研究组患者皮下注射优泌乐25R治疗。结果两组患者治疗治疗前的FPG、2hPG、HbA1c水平比较均差异无统计学意义(P>0.05),治疗后研究组患者FPG、2hPG、HbA1c水平均较对照组患者低(P<0.05)。研究组患者血糖水平达标时间较对照组患者早(P<0.05),低血糖发生率为6.7%,较对照组患者的20.0%低(P<0.05)。结论优泌乐25R治疗血糖控制不佳2型糖尿病,能够快速对患者血糖水平进行有效控制,低血糖发生率低,安全性高,具有临床深入推广应用价值。
Objective To investigate the efficacy and safety of eucalyptus 25R in the treatment of poor glycemic control in type 2 diabetes.Methods 60 patients with poor glycemic control type 2 diabetes admitted to our hospital were randomly divided into study group and control group.The patients in the control group were treated with subcutaneous injection of insulin aspart 30,and the patients in the study group were given subcutaneous injection of eucalyptus 25R.Results There were no significant differences in the levels of FPG,2 hPG and HbA1c between the two groups before treatment (P>0.05).The levels of FPG,2 hPG and HbA1c in the study group were lower than those in the control group (P<0.05).The blood glucose level of the study group was earlier than that of the control group (P<0.05),and the incidence of hypoglycemia was 6.7%,which was lower than that of the control group (20%)(P<0.05).Conclusion Eucalyptus 25R can effectively control the blood glucose level of patients with poor glycemic control type 2 diabetes.The incidence of hypoglycemia is low and the safety is high.It has clinical application value.
作者
吕志威
曾丰年
龚丽友
LYU Zhi-wei;ZENG Feng-nian;GONG Li-you(Department of General Internal Medicine,Shanwei Second People's Hospital (Shanwei Yihui Fund Hospital),Shanwei,Guangdong Province,516600 China)
出处
《糖尿病新世界》
2019年第8期78-79,共2页
Diabetes New World Magazine
